stockrow
Friday 6 November 2026
Export ITGR’s income statement to Excel — free account
Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
126.56
0.19
−0.15%
Follow ITGR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
26.86 | 21.67 | 25.33 | 42.11 |
P/S ratio |
1.47 | 1.63 | 1.72 | 2.36 | |
P/FCF ratio |
26.17 | 30.52 | 28.64 | 53.20 | |
P/Operating CF |
49.16 | 122.15 | 53.21 | 117.37 | |
P/B ratio |
1.56 | 1.78 | 1.85 | 2.49 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.12 | 2.32 | 2.41 | 3.04 | |
EV/EBITDA |
10.93 | 12.46 | 13.75 | 18.73 | |
EV/Operating CF |
19.99 | 22.75 | 21.64 | 31.47 | |
EV/FCF |
37.66 | 43.63 | 40.06 | 68.72 | |
Quick Ratio |
1.57 | 1.63 | 1.66 | 1.79 | |
Current Ratio |
3.32 | 3.75 | 3.73 | 3.98 | |
Net Debt/EBITDA |
12.85 | 18.92 | 17.93 | 19.54 | |
Debt/Assets |
35.59% | 38.22% | 37.66% | 37.39% | |
Debt/Equity |
0.69 | 0.77 | 0.75 | 0.74 | |
Asset Turnover |
0.57 | 0.55 | 0.54 | 0.54 | |
Operating CF/Net income |
1.14 | 1.50 | 2.53 | 2.45 | |
Capex/Depreciation |
(0.74) | (0.65) | (0.63) | (0.57) | |
Interest Coverage |
6.03 | 3.27 | 3.41 | 2.91 | |
Research and Development Expense of Revenue |
2.14% | 3.70% | 2.43% | 3.01% | |
Selling, General and Administrative Expense of Revenue |
12.12% | 13.36% | 12.43% | 12.04% | |
Intangible Assets out of Total Assets |
0.57 | 0.56 | 0.55 | 0.55 | |
Share Based Compensation of Revenue |
1.22% | 1.52% | 1.16% | 1.16% | |
Graham Net Nets |
(0.33) | (0.31) | (0.28) | (0.20) | |
Graham Number |
57.48 | 67.25 | 64.78 | 58.52 | |
Earnings Yield |
3.72% | 4.61% | 3.95% | 2.37% | |
Free Cash Flow Yield |
3.82% | 3.28% | 3.49% | 1.88% | |
Revenue per Share |
13.59 | 12.82 | 13.65 | 13.21 | |
Operating CF per Share |
1.60 | 0.72 | 1.76 | 1.08 | |
Capex per Share |
(0.79) | (0.70) | (0.67) | (0.60) | |
Free Cash Flow per Share |
0.80 | 0.02 | 1.09 | 0.47 | |
Cash per Share |
0.49 | 0.24 | 0.63 | 0.42 | |
Shareholders Equity per Share |
50.28 | 49.50 | 50.54 | 50.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
50.28 | 49.50 | 50.54 | 50.74 | |
Free Cash Flow |
27.94 | 0.79 | 36.99 | 16.10 | |
Working Capital |
538.06 | 568.42 | 593.49 | 600.27 | |
Capital Expenditures |
(27.48) | (23.90) | (22.75) | (20.53) | |
Net Current Asset Value |
(893.84) | (940.06) | (894.21) | (866.15) | |
EV/EBIT |
17.72 | 21.18 | 24.87 | 36.89 | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 | |
Price to Operating Income |
12.31 | 14.82 | 17.78 | 28.56 | |
| Other line items | |||||
Average Receivables |
295.67 | 302.01 | 320.50 | 327.62 | |
Average Payables |
107.31 | 113.51 | 114.61 | 110.87 | |
Average Inventory |
250.43 | 272.29 | 277.25 | 271.06 | |
Average Assets |
3,244.27 | 3,354.71 | 3,397.27 | 3,395.62 | |
Average Common Equity |
1,682.93 | 1,651.80 | 1,711.14 | 1,736.12 |
Columns are period end dates · fundamentals updated 2 Nov 2026